Showing results (151-160 of 273) with videos related to
Sort By:
Pageof 28
Genes, Chromosomes & Cancer|January 1, 1997
Genomic instability in sporadic colorectal cancer quantitated by inter-simple sequence repeat PCR analysisM Basik, D L Stoler, K C Kontzoglou, et al.Physical Review Letters|May 15, 2018
π and 4π Josephson Effects Mediated by a Dirac SemimetalW Yu, W Pan, D L Medlin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1995
A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomasM A Rodriguez, F C Cabanillas, F B Hagemeister, et al.Physical Chemistry Chemical Physics : PCCP|November 23, 2019
Molecular dynamics discovery of an extraordinary ionic migration mechanism in dislocation-containing TlBr crystalsX W Zhou, M E Foster, P Yang, et al.Artificial Organs|April 12, 2000
Pathological mineralizations: calcifications and Si-bearing particles in soft tissues and their eventual relationship to different prosthesesA G Leyva, S L Maguid, M A Rodriguez de Benyacar, et al.The Journal of Pharmacology and Experimental Therapeutics|March 29, 2000
Oxidative stress induced by tert-butyl hydroperoxide causes vasoconstriction in the aorta from hypertensive and aged rats: role of cyclooxygenase-2 isoformE C Garcia-Cohen, J Marin, L D Diez-Picazo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomasF B Hagemeister, R Khetan, P Allen, et al.Kidney International|January 1, 1996
Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuriaJ R Weisinger, E Alonzo, E Bellorín-Font, et al.Journal of the National Cancer Institute|November 2, 1988
Chemotherapy with dexamethasone, high-dose cytarabine, and cisplatin for parenchymal brain lymphomaP McLaughlin, W S Velasquez, J R Redman, et al.Cancer|June 20, 2001
Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphomaR B Wilder, M A Rodriguez, C S Ha, et al.Pageof 28